Medicament for treating acute inflammatory demyelinating polyneuropathies and preparation method of medicament

Abstract

The invention relates to a medicament for treating acute inflammatory demyelinating polyneuropathies and a preparation method of the medicament. The medicament is prepared from the following components in parts by weight: 9-14 parts of oryzanol, 6-11 parts of Chinese taxillus twigs, 5-10 parts of obscured homalomena rhizome, 6-12 parts of frankincense, 4-11 parts of towel gourd vegetable sponge, 5-10 parts of common curculigo rhizome, 6-9 parts of pitaya flower, 5-8 parts of claoxylon polot, 5-11 parts of root of water nightshade, 6-12 parts of red madder, 5-10 parts of amur corktree bark, 5-10 parts of conical redpepper fruits, 6-11 parts of mountain oranges, 5-12 parts of songaria cynomorium herb, 5-10 parts of wolfberry root, 6-11 parts of eucommia bark, 5-10 parts of officinal magnolia bark, 4-8 parts of caper euphorbia seeds and 5-9 parts of solidago Canadensis. The medicament provided by the invention has a great effect on treatment of acute inflammatory demyelinating polyneuropathies. The preparation method comprises the processes of grinding, sealing and the like, and the method is simple, applicable, easy to operate and conductive to popularization and application.

Description

Technical field [0001] The present invention involves a drug and preparation method of acute inflammatory desertemic hypotina. Background technique [0002] Acute inflammatory deserticiasis multi -neuropathy, the main lesion is the inflammatory depaidity of neuropathy surrounding the nerve root. Sometimes it also affects spinal, spinal cord and brain, and clinical characteristics to develop rapidly limb symmetry and weakness.Disappearing.Those with severe condition have experienced marrow and respiratory muscle paralysis and life -threatening.This disease occurs mostly in young people and children. Men are slightly more, and there are slightly more in winter and summer.About 2 / 3 patients have a history of upper respiratory or digestive tract infection a few days to weeks before the onset.At present, the treatment of this disease generally uses plasma exchange, immunoglobulin intravenous injection and other methods, and oral oral methods of western medicine. Patients with the abov...

AI Technical Summary

Problems solved by technology

At present, plasma exchange, intravenous infusion of immunoglobulin, etc., and oral administration of western medicine are generally used to treat this disease. During the treatment process of the above-mentioned methods, the patients suffer great pain, and the side effects are relatively large, and even heart failure and other symptoms may occur, which has certain risks. sex